Analysis of Hematoma Following Breast Surgery
Retrospective Review of Patient Records for Analysis of Postoperative Bleeding Following Breast Surgery
1 other identifier
observational
20
1 country
1
Brief Summary
A retrospective review of patients who developed hematoma following breast surgery from 2003 to 2018 in a single institution was performed. The study investigated the value of closed-suction drains regarding the quantity and quality of fluid secretion for the prediction of subcutaneous hematoma in patients undergoing breast surgery procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2018
CompletedFirst Submitted
Initial submission to the registry
April 22, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 22, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 22, 2018
CompletedFirst Posted
Study publicly available on registry
May 3, 2018
CompletedMay 3, 2018
April 1, 2018
2 months
April 22, 2018
April 22, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Drain fluid volume
The drain fluid volume in the breast affected by hematoma was compared to the non-hematoma side.
24 hours postoperatively
Study Arms (2)
Hematoma side
Drain secretion volume prior to revision surgery on the breast side affected by hematoma.
Non-hematoma side
Drain secretion volume prior to revision surgery on the breast side not affected by hematoma.
Interventions
To evaluate the clinical value of postoperative drain fluid volume for detection of hematoma, an intra-individual comparison of drain secretion volumes between sides affected by hematoma and the uneventful contralateral breasts was performed.
Eligibility Criteria
We enrolled 20 subjects who developed unilateral hematoma requiring evacuation following bilateral breast surgery between January 2008 and January 2018 at our institution. Gender, age, breast surgery subtype, preoperative and postoperative hemoglobin values as well as perioperative heparinization were recorded.
You may qualify if:
- Patients who developed hematoma requiring revision following bilateral breast surgery including augmentation mammoplasty, subcutaneous mastectomy and breast reduction.
You may not qualify if:
- Patients who developed hematoma requiring revision following unilateral breast surgery.
- Breast surgery in absence of hematoma.
- Patients with known coagulation disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Plastic Surgery, University Hospital of Regensburg
Regensburg, 93055, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Plastic surgery resident
Study Record Dates
First Submitted
April 22, 2018
First Posted
May 3, 2018
Study Start
March 1, 2018
Primary Completion
April 22, 2018
Study Completion
April 22, 2018
Last Updated
May 3, 2018
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share